Diabetic Cardiomyopathy: Pathophysiology Considerations and Management
Diabetic Cardiomyopathy
Abstract
Diabetes mellitus (DM) is nowadays considered an epidemic in the industrialized world. Among other complications, it affects the heart and is accompanied by an increased cardiovascular mortality. The development of heart failure (HF) in DM occurs independently of any coronary artery disease or hypertension, and this entity is termed “diabetic cardiomyopathy”. Cardiac hypertrophy, abnormal ventricular strain features, diastolic dysfunction and subsequently systolic impairment are the cardinal imaging characteristics. The pathophysiology of the disease is complex and multifactorial and, as a consequence, the therapeutic options, on top of the conventional HF medications, should aim at reversing the pathophysiological processes. Hereby we briefly review the manifestations of diabetic cardiomyopathy, describe the pathogenetic mechanisms and discuss the potential therapeutic targets. Rhythmos 2019;14(4):71-76.
Downloads
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
